Harmonizing Perspectives on MPS II Care in Türkiye: A Delphi Study Towards Treatment Management Consensus.

Neslihan Onenli Mungan, Leyla Tumer, Serap Sivri, Nur Arslan, Sema Kalkan Ucar, Berna Seker Yilmaz, Gulden Gokcay

Abstract read

In one paragraph

Article in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Neslihan Onenli MunganDepartment of Pediatrics, Division of Pediatric Metabolism, Cukurova University Faculty of Medicine, Adana 01790, Türkiye.ORCID 0000-0001-7862-3038

Leyla TumerDepartment of Pediatrics, Division of Pediatric Metabolism, Gazi University Faculty of Medicine, Ankara 06500, Türkiye.

Serap SivriDepartment of Pediatrics, Division of Pediatric Metabolism, Hacettepe University Faculty of Medicine, Ankara 06230, Türkiye.ORCID 0000-0001-8260-9984

Nur ArslanDepartment of Pediatrics, Division of Pediatric Metabolism, Dokuz Eylul University Faculty of Medicine, İzmir 35340, Türkiye.

Sema Kalkan UcarDepartment of Pediatrics, Division of Pediatric Metabolism, Ege University Faculty of Medicine, İzmir 35100, Türkiye.

Berna Seker YilmazGenetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.ORCID 0000-0003-0425-0341

Gulden GokcayDepartment of Pediatrics, Division of Pediatric Nutrition and Metabolism, Istanbul University Faculty of Medicine, Istanbul 34093, Türkiye.ORCID 0000-0003-3726-5726

Funding

Pfizer Turkey N/A

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Delphi methodenzyme replacement therapyHunter syndromemucopolysaccharidosis type II (MPS II)rare disease consensus

Identifiers

PMID42121657

DOI10.3390/healthcare14091214

PMCPMC13164175

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.